Could R1 RCM Inc (RCM) See a Reversal After This Very Strong Session?

September 17, 2017 - By Michael Collier

The stock of R1 RCM Inc (NASDAQ:RCM) is a huge mover today! The stock increased 4.44% or $0.14 on September 15, reaching $3.29. About 686,739 shares traded or 168.68% up from the average. R1 RCM Inc (NASDAQ:RCM) has 0.00% since September 17, 2016 and is . It has underperformed by 16.70% the S&P500.
The move comes after 9 months positive chart setup for the $330.40M company. It was reported on Sep, 17 by Barchart.com. We have $3.45 PT which if reached, will make NASDAQ:RCM worth $16.52M more.

Analysts await R1 RCM Inc (NASDAQ:RCM) to report earnings on November, 1. They expect $-0.03 earnings per share, down 116.67 % or $0.21 from last year’s $0.18 per share. After $-0.11 actual earnings per share reported by R1 RCM Inc for the previous quarter, Wall Street now forecasts -72.73 % EPS growth.

More notable recent R1 RCM Inc (NASDAQ:RCM) news were published by: Globenewswire.com which released: “R1 RCM Inc. to Ring The Nasdaq Stock Market Opening Bell” on March 14, 2017, also Seekingalpha.com with their article: “R1 RCM’s (RCM) CEO Joseph Flanagan on Q1 2017 Results – Earnings Call Transcript” published on May 10, 2017, Seekingalpha.com published: “R1 RCM’s (RCM) CEO Joseph Flanagan on Q2 2017 Results – Earnings Call Transcript” on August 03, 2017. More interesting news about R1 RCM Inc (NASDAQ:RCM) were released by: Chicagobusiness.com and their article: “After years of turmoil, Accretive Health ditches name” published on January 06, 2017 as well as Globenewswire.com‘s news article titled: “R1 RCM Reports Fourth Quarter and Full Year 2016 Results” with publication date: March 01, 2017.

R1 RCM Inc., formerly Accretive Health, Inc., is a well-known provider of revenue cycle management and physician advisory services (PAS) to healthcare providers. The company has market cap of $330.40 million. The Firm is engaged in providing management services of revenue cycle activities for the United States hospitals and other medical services providers. It currently has negative earnings. The Company’s primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.